Merck Vioxx Corporate Integrity Agreement and Continuing Medical Education…
Recently Merck agreed to pay $950 million and pleaded guilty to a criminal charge over the marketing and sales of the painkiller…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Medicare Fraud: The Case of HHS Spending $77 Million to Find $7,591 in…
According to a recent article from the Associated Press, “a computer initiative to stop fraudulent Medicare billing at…
Marrying Earlier Life Science Research with Financing
Sanofi CEO Chris Viehbacher recently spoke with journalists during the recent CED Life Sciences Conference in Raleigh, North…
HHS OIG Budget FY 2013 Compliance Assistance and Enforcement
The Department of Health and Human Services (HHS) released its FY 2013 budget for its various offices and sub-agencies, including…
HHS Regulatory Priorities for 2012
The Department of Health and Human Services (HHS) recently released a report of its Regulatory Priorities for FY 2012.…
Study Dispels the Myth of Publication Bias in Industry Supported Rheumatoid…
A recent study published in the Journal of Arthritis & Rheumatism assessed the association of industry funding with the…
HHS OIG: Pharmaceutical Compliance Roundtable 2012 Report
As we have covered numerous times over the past few years, pharmaceutical and medical device manufacturers have been increasingly…
HHS Global Health Strategy 2012
The Department of Health and Human Services (HHS) published its “Global Health Strategy” (GHS). Although the chief mission of HHS…
FDA Advisory Committee Vacancies and Interests
Advisory Committees at the Food and Drug Administration (FDA) are receiving a lot of attention lately. Most of the concerns…
Physician Payment Sunshine: Rockpointe a Medical Education Company Comments…
Rockpointe, Inc. recently submitted comments regarding Section 6002 of the Patient Protection Affordable Care Act (PPACA)—also…